Trials / Completed
CompletedNCT04896957
Perceptions and Representations of Vaccination Against COVID-19
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 14 (actual)
- Sponsor
- Centre Hospitalier Intercommunal Creteil · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
SARS COV2, the virus that causes COVID-19, was first described in Wuhan, China. For this pathology, which causes severe respiratory infections, preventing the transmission of the virus has become fundamental, that is why vaccines have been developed. In France, this vaccination campaign took place in a context where the lack of confidence in vaccination is high: According to a November 2020 IFOP poll, only 41% of French respondents were willing to be vaccinated against COVID-19. To our knowledge, there are still few qualitative studies on vaccination on the current issue of vaccination against COVID-19.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Interview | Face to face semi-directed interviews about perceptions, representations and experiences of Covid-19 vaccination, including six opened-questions |
Timeline
- Start date
- 2021-09-01
- Primary completion
- 2022-09-01
- Completion
- 2022-09-01
- First posted
- 2021-05-21
- Last updated
- 2022-12-02
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04896957. Inclusion in this directory is not an endorsement.